Spontaneous breakage and fragile site expression in chronic lymphocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 103, Issue 2, 1998, Pages 144-148

  Fundia, Ariela ^a   Giere, Isabel ^a   Larripa, Irene ^a   Slavutsky, Irma ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; FLOXURIDINE;

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME FRAGILE SITE; CHROMOSOME STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; GENETIC PREDISPOSITION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0032104075     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00392-0     Document Type: Article

References (32)

1. Döhner H, Pilz T, Fischer K, Cabot G, Diehl D, Fink T, Stilgenbauer S, Bentz M, Lichter P (1994): Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. Leuk Lymphoma 16:97-103.
2. Crossen PE (1989): Cytogenetic and molecular changes in chronic B-cell leukemia. Cancer Genet Cytogenet 43:143-150.
3. Oscier DG (1994): Cytogenetic and molecular abnormalities in chronic lymphocytic leukemia. Blood Rev 8:88-97.
4. German J (1983): Patterns of neoplasia associated with the chromosome-breakage syndromes. In: Chromosome Mutation and Neoplasia. J German, ed. Alan R. Liss, New York, p. 97.
5. Hsu TC (1983): Genetic instability in the human population: a working hypothesis. Hereditas 98:1-9.
6. Carrano AV (1986): Chromosomal alterations as markers of exposure and effect. J Occup Med 28:1112-1116.
7. Sutherland GR, Hecht F (1985): Fragile Sites on Human Chromosomes. Oxford University Press, New York.
8. Le Beau MM (1988): Chromosomal fragile sites and cancer specific breakpoints: A moderating viewpoint. Cancer Genet Cytogenet 31:55-62.
9. Wenger SL (1992): Relationship between fragile sites and cancer breakpoints. Cancer Genet Cytogenet 61:213.
10. Chary-Reddy S, Prasad VS, Ahuja YR (1994): Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency. Cancer 86:111-117.
11. Buckton KE, Evans HJ (1982): Human peripheral blood lymphocyte cultures: an in vitro assay for the cytogenetic effects of environmental mutagens. In: Cytogenetic Assays of Environmental Mutagens. TC Hsu, ed. Allanheld, Osmun and Co., Ottowa, pp. 183-202.
12. Heim S, Johansson B, Mertens F (1989): Constitutional chromosome instability and cancer risk. Mutation Res 221:39-51.
13. Sutherland GR (1991): Chromosomal fragile sites. GATA 8:161-166.
14. Dobkin C, Zhong N, Brown WT (1996): The molecular basis of fragile sites. Am J Hum Genet 59:478.
15. Nayak BN, Ray M (1989): Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 39:99-102.
16. Berger R, Bloomfield CD, Sutherland GR (1985): Report of the commitee on chromosome rearrangements in neoplasia and on fragile sites. Human gene mapping 8: eighth international workshop on human gene mapping. Cytogenet Cell Genet 40:490-535.
17. Human Gene Mapping 11 (1991): The catalog of mapped genes and report of the nomenclature committee. Cytogenet Cell Genet 58:5-102.
18. Mitelman F (1991): Catalog of Chromosome Aberrations in Cancer, ed 4. Wiley-Liss, Inc., New York.
19. Mitelman F, Kaneko Y, Trent J (1991): Report of the committee on chromosome changes in neoplasia: human Gene Mapping 11. Cytogenet Cell Genet 58:1053-1079.
20. Heim S, Mitelman F (1995): Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. ed 2. Wiley-Liss, Inc., New York.
21. Oscier DG, Stevens J, Hamblin TJ, Pickering RM, Lambert R, Fitchett M (1990): Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br J Haematol 76:352-358.
22. Gahrton G, Robert KH, Friberg K, Juliusson G, Biberfeld P, Zech L (1982): Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders. Nature 297:513-514.
23. Fundia AF, Slavutsky IR, Larripa IB (1990): Expresion de sitios fragiles nuevos detectados en pacientes con procesos linfoproliferativos. Sangre 35:4-9.
24. Craig-Holmes AP, Strong LC, Goodacre A, Pathak S (1987): Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet 76:134-137.
25. Tedeschi B, Vernole P, Sanna ML, Nicoletti B (1992): Population cytogenetics of aphidicolin-induced fragile sites. Hum Genet 89:543-547.
26. Green RJ, Phillips DL, Chen ATL, Reidy JA, Ragab AH (1988): Effects of folate in culture medium on common fragile sites in lymphocyte chromosomes from normal and leukemic children. Hum Genet 81:9-12.
27. Yunis JJ, Soreng AL, Bowe AE (1987): Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1:59-69.
28. Käkönen M (1988): Population cytogenetics of folate-sensitive fragile sites I: Common fragile sites. Hum Genet 80:344-348.
29. Moormeier JA, Neilly ME, Vardiman JW, Le Beau MM, Golomb HM (1991): Familial lymphoproliferative disorders with chromosomal fragile site analysis. Leuk Lymphoma 5:311-316.
30. Wang YL, Tang ZZ, Hu N, Wang XQ (1990): Observations of fragile sites in patients with lymphoma and leukemia. Chin Med J Engl 103:565-571.
31. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, et al. (1996): The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-598.
32. Sozzi G, Veronese ML, Negrini M, Baffa R, Coticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U (1996): The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17-26.